Handelsbanken Fonder AB »

Beam Therapeutics shares owned by Handelsbanken Fonder AB

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Handelsbanken Fonder AB from 13F filings

Historical chart of Handelsbanken Fonder AB investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Handelsbanken Fonder AB

Quarter filed Position value Share count Share price at filing
2023-12-31 $460k 17k 27.22
2023-09-30 $253k 11k 24.10
2023-06-30 $335k 11k 31.90
2023-03-31 $288k 9.4k 30.64
2022-12-31 $368k 9.4k 39.15
2022-09-30 $210k 4.4k 47.73
2022-03-31 $510k 8.9k 57.30
2021-12-31 $709k 8.9k 79.66
2021-09-30 $713k 8.2k 86.95
2021-06-30 $1.1M 8.2k 128.66
2021-03-31 $536k 6.7k 80.00
2020-12-31 $547k 6.7k 81.64